Xing-Zhen Sun1, Shu-Yan Li2, Xiang-Yang Tian3, Qing-Quan Wu4. 1. Department of Pediatrics, Huai'an First People's Hospital, Nanjing Medical University Huai'an 223300, China. 2. Department of Ophthalmology, Huai'an First People's Hospital, Nanjing Medical University Huai'an 223300, China. 3. Department of Neurology, Huai'an First People's Hospital, Nanjing Medical University Huai'an 223300, China. 4. Department of Cardiothoracic Surgery, Huai'an First People's Hospital, Nanjing Medical University Huai'an 223300, China.
Abstract
OBJECTIVE: To investigate whether right ventricular hypertrophy in hypoxic pulmonary hypertension (HPH) rats could be prevented by treatment with Rho kinase inhibitor fasudil. METHODS: The rat model of pulmonary hypertension was established by exposing rats to normobaric intermitent hypoxia [(10 ± 0.5)% O2]. Twenty-four Spraque-Dawley male rats were randomly divided into control group, hypoxic model group and hypoxia with fasudil groups (n=8 each). The mean pulmonary arterial pressure (mPAP), and right ventricle hypertrophy index (RVHI) were measured. Ultrastructure of the right ventricular myocardial cells was observed under transmission electron microscope (TEM). - RESULTS: The level of mPAP (31.38 ± 1.98) mmHg and RVHI (0.47 ± 0.03) were significantly higher in the hypoxic model group than (15.25 ± 0.91) mmHg and (0.25 ± 0.02) in control group respectively (P<0.01). Transmission electron microscope (TEM) revealed the model group right ventricular mitochondria increased significantly, swelling, cristae blurred, lost, heart muscle Siming dark band was not clear. The level of mPAP (16.63 ± 1.53) mmHg and RVHI (0.27 ± 0.02) were significantly lower in fasudil treatment group than in model group respectively (P<0.01). After the intervention of fasudil right ventricular myocardial injury was significantly reduced. CONCLUSIONS: Fasudil may partly prevent and reverse the development of pulmonary hypertension and right ventricular hypertrophy and myocardial cell injury.
OBJECTIVE: To investigate whether right ventricular hypertrophy in hypoxic pulmonary hypertension (HPH) rats could be prevented by treatment with Rho kinase inhibitor fasudil. METHODS: The rat model of pulmonary hypertension was established by exposing rats to normobaric intermitent hypoxia [(10 ± 0.5)% O2]. Twenty-four Spraque-Dawley male rats were randomly divided into control group, hypoxic model group and hypoxia with fasudil groups (n=8 each). The mean pulmonary arterial pressure (mPAP), and right ventricle hypertrophy index (RVHI) were measured. Ultrastructure of the right ventricular myocardial cells was observed under transmission electron microscope (TEM). - RESULTS: The level of mPAP (31.38 ± 1.98) mmHg and RVHI (0.47 ± 0.03) were significantly higher in the hypoxic model group than (15.25 ± 0.91) mmHg and (0.25 ± 0.02) in control group respectively (P<0.01). Transmission electron microscope (TEM) revealed the model group right ventricular mitochondria increased significantly, swelling, cristae blurred, lost, heart muscle Siming dark band was not clear. The level of mPAP (16.63 ± 1.53) mmHg and RVHI (0.27 ± 0.02) were significantly lower in fasudil treatment group than in model group respectively (P<0.01). After the intervention of fasudil right ventricular myocardial injury was significantly reduced. CONCLUSIONS:Fasudil may partly prevent and reverse the development of pulmonary hypertension and right ventricular hypertrophy and myocardial cell injury.
Entities:
Keywords:
Fasudil; pulmonary hypertension; rat; right ventricular hypertrophy
Authors: Aiping Liu; David Schreier; Lian Tian; Jens C Eickhoff; Zhijie Wang; Timothy A Hacker; Naomi C Chesler Journal: Am J Physiol Heart Circ Physiol Date: 2014-06-06 Impact factor: 4.733
Authors: Michelle J Connolly; Jesus Prieto-Lloret; Silke Becker; Jeremy P T Ward; Philip I Aaronson Journal: J Physiol Date: 2013-06-17 Impact factor: 5.182
Authors: Akylbek Sydykov; Argen Mamazhakypov; Abdirashit Maripov; Djuro Kosanovic; Norbert Weissmann; Hossein Ardeschir Ghofrani; Akpay Sh Sarybaev; Ralph Theo Schermuly Journal: Int J Environ Res Public Health Date: 2021-02-10 Impact factor: 3.390